Literature DB >> 7904890

Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices.

P W Gean1, C C Huang, C R Hung, J J Tsai.   

Abstract

The mechanism of action of the anticonvulsant drug valproic acid (VPA) was studied in rat amygdaloid slices using intracellular recording techniques. In the presence of bicuculline (20 microM), stimulation of the endopyriform nucleus evoked an excitatory postsynaptic potential (EPSP) followed by a paroxysmal depolarizing shift (PDS). Superfusion of VPA (2 mM) reversibly suppressed the PDS. Synaptic response mediated by the N-methyl-D-aspartate (NMDA) receptors (EPSPNMDA) was isolated pharmacologically by application of a solution containing nonNMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and gamma-aminobutyric acid receptor antagonist bicuculline (20 microM). VPA (0.2-10 mM) reversibly reduced the amplitude of the EPSPNMDA in a dose-dependent manner. Higher concentration of VPA (10 mM), in addition, suppressed the normal synaptic transmission. These results suggest that VPA's anticonvulsant effect is due, at least in part, to its blocking action on the EPSPNMDA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7904890     DOI: 10.1016/0361-9230(94)90202-x

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  18 in total

1.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

Review 2.  Low threshold T-type calcium channels as targets for novel epilepsy treatments.

Authors:  Kim L Powell; Stuart M Cain; Terrance P Snutch; Terence J O'Brien
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

Review 3.  Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly.

Authors:  Anton P Porsteinsson
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  Molecular and therapeutic potential and toxicity of valproic acid.

Authors:  Sébastien Chateauvieux; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  J Biomed Biotechnol       Date:  2010-07-29

Review 5.  Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex.

Authors:  Gabriella Gobbi; Luigi Janiri
Journal:  Psychopharmacology (Berl)       Date:  2006-02-22       Impact factor: 4.530

7.  Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.

Authors:  Mireille Basselin; Lisa Chang; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

8.  Spatiotemporal dynamics of high-K+-induced epileptiform discharges in hippocampal slice and the effects of valproate.

Authors:  Jian-Sheng Liu; Jing-Bo Li; Xin-Wei Gong; Hai-Qing Gong; Pu-Ming Zhang; Pei-Ji Liang; Qin-Chi Lu
Journal:  Neurosci Bull       Date:  2013-01-30       Impact factor: 5.203

9.  Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain.

Authors:  Mireille Basselin; Nelly E Villacreses; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Biol Psychiatry       Date:  2007-07-12       Impact factor: 13.382

10.  Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy.

Authors:  Ghaydaa A Shehata; Abd El-aziz M Bateh; Sherifa A Hamed; Tarek A Rageh; Yaser B Elsorogy
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.